Status:
UNKNOWN
Health and QoL in Oncological Patients: Management of Bone Pathology in Italian Citbl Population
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Breast Cancer Female
Osteoporosis
Eligibility:
FEMALE
18-75 years
Brief Summary
Studying the current state of the clinical approaches to bone diseases in breast cancer patients treated with adjuvant and/or hormone therapy
Eligibility Criteria
Inclusion
- Patients willing to provide the Informed consent to participate to the study
- Women aged 18-75 years
- Patients having breast cancer, with no phenotype restrictions
- Patients in natural and stable menopause
- Patients having secondary amenorrhea, that arose after the initiation of oncologic treatment, since at least 12 months or 6 months with FSH\> 40 U/I
Exclusion
- Patients with advanced cancer and/or bone metastases and/or visceral metastases
- Patients with severe renal insufficiency and/or in dialysis and patients affected by severe endocrine disorders
Key Trial Info
Start Date :
July 26 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 26 2021
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT04055805
Start Date
July 26 2018
End Date
October 26 2021
Last Update
February 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Policlinico Agostino Gemelli
Roma, RM, Italy, 00168